![](/img/cover-not-exists.png)
Does lapatinib, a small-molecule tyrosine kinase inhibitor, constitute a breakthrough in the treatment of breast cancer?
Yoshinori Ito, Nahomi Tokudome, Tsutomu Sugihara, Shunji Takahashi, Kiyohiko HatakeVolume:
14
Language:
english
Pages:
7
DOI:
10.2325/jbcs.971
Date:
April, 2007
File:
PDF, 697 KB
english, 2007